Related Experiment Video
Updated: Aug 30, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Direct stenting with 3000 i.u. heparin
Christophe Caussin1, Abdelhamid Fsihi, Alice Ohanessian
1Hôpital Marie Lannelongue, Le Plessis Robinson, France. caussin@ccml.fr
Insights
This study found that direct stenting with 3000 IU heparin and immediate sheath removal is a safe percutaneous transluminal coronary angioplasty (PTCA) strategy, significantly reducing vascular complications in selected patients.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Medicine
Background:
- Vascular complications are a concern during percutaneous transluminal coronary angioplasty (PTCA).
- Predictive factors for these complications include heparin dosage, sheath dwell time, and use of anti-glycoprotein (GP) IIb/IIIa inhibitors.
- A simplified PTCA approach may allow reduced heparinization and no anti-GP IIb/IIIa use in select cases.
Purpose of the Study:
- To assess the safety and feasibility of a novel PTCA strategy.
- This strategy involves direct stenting with a low heparin dose (3000 IU) and immediate sheath removal.
- To evaluate the rate of vascular complications associated with this simplified PTCA technique.
Main Methods:
- A prospective study screened 716 consecutive PTCA patients from April 1999 to April 2000.
- 171 patients meeting specific inclusion criteria (excluding acute myocardial infarction and TIMI grade zero flow) were enrolled.
- Patients received 3000 IU heparin before direct stenting, followed by immediate sheath removal via manual compression.
Main Results:
- The study successfully completed the protocol in 150 patients (88%), with an average activated clotting time of 179 +/- 32 seconds.
- No subacute thrombosis or creatine kinase elevation was observed before discharge.
- Only minor vascular complications were reported: two uncomplicated groin hematomas and two false aneurysms (one requiring surgical repair).
Conclusions:
- Direct stenting combined with 3000 IU heparin and immediate sheath removal is a safe PTCA strategy.
- This simplified approach is feasible and associated with a low rate of major vascular complications.
- This technique offers a potentially safer alternative for selected patients undergoing PTCA.
Abstract:
In order to reduce vascular complications, the authors assessed safety and feasability of a new percutaneous transluminal coronary angioplasty (PTCA) strategy consisting of direct stenting with 3000 i.u. heparin and immediate sheath removal. Predicting factors of vascular complications during PTCA include heparin dosages, sheath dwell time and use of anti-glycoprotein (GP) IIb/IIIa. A simplified PTCA with direct stenting technique may allow the use of very low doses of heparin without anti-GPIIb/IIIa in selected cases. From April 1999 to April 2000 all patients who underwent PTCA in the authors' center were screened. Exclusion criteria comprised a contraindication for direct stenting, primary PTCA for acute myocardial infarction (MI) and a TIMI (thrombolysis in myocardial infarction) grade zero flow. All other patients were included. They received 3000 i.u. heparin before direct stenting whatever their current anticoagulation and their weight. The sheath was immediately removed using manual compression. Out of 716 consecutive PTCA patients, 171 (24%) were enrolled in the study (198 sites). Complete protocol was achieved in 150 patients (88%). Activated clotting time during the procedure was 179 +/- 32 seconds. No subacute thrombosis or creatine kinase elevation was observed before discharge. Only two uncomplicated groin hematomas and two false aneurysms (one surgical repair) were noted. This study shows that direct stenting with 3000 iu heparin is safe. Immediate sheath removal can be performed with a low rate of major vascular complications.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Cardiac Catheterization IV: Nursing Management